X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TEVA PHARMA
Dec-13
ALKEM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5892,913-   
Low Rs1,2322,530-   
Sales per share (Unadj.) Rs417.51,671.6-  
Earnings per share (Unadj.) Rs56.3104.4-  
Cash flow per share (Unadj.) Rs64.7239.5-  
Dividends per share (Unadj.) Rs12.7091.41-  
Dividend yield (eoy) %0.93.4 26.8%  
Book value per share (Unadj.) Rs292.91,856.8-  
Shares outstanding (eoy) m119.57848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.6 207.5%   
Avg P/E ratio x25.126.1 96.1%  
P/CF ratio (eoy) x21.811.4 191.9%  
Price / Book Value ratio x4.81.5 328.5%  
Dividend payout %22.687.5 25.8%   
Avg Mkt Cap Rs m168,6532,307,764 7.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM31,538.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,970.2-  
INCOME DATA
Net Sales Rs m49,9151,417,511 3.5%  
Other income Rs m1,6450-   
Total revenues Rs m51,5611,417,511 3.6%   
Gross profit Rs m8,482388,186 2.2%  
Depreciation Rs m1,006114,579 0.9%   
Interest Rs m67127,842 2.4%   
Profit before tax Rs m8,451245,765 3.4%   
Minority Interest Rs m-1141,116 -10.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-161,331 0.0%   
Tax Rs m1,606-3,001 -53.5%   
Profit after tax Rs m6,73188,551 7.6%  
Gross profit margin %17.027.4 62.1%  
Effective tax rate %19.0-1.2 -1,556.5%   
Net profit margin %13.56.2 215.9%  
BALANCE SHEET DATA
Current assets Rs m27,062957,382 2.8%   
Current liabilities Rs m15,324834,918 1.8%   
Net working cap to sales %23.58.6 272.2%  
Current ratio x1.81.1 154.0%  
Inventory Days Days6791 73.2%  
Debtors Days Days4196 43.0%  
Net fixed assets Rs m12,610462,990 2.7%   
Share capital Rs m2393,489 6.9%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,0271,574,586 2.2%   
Long term debt Rs m1,212724,805 0.2%   
Total assets Rs m54,3873,239,467 1.7%  
Interest coverage x13.69.8 138.4%   
Debt to equity ratio x00.5 7.5%  
Sales to assets ratio x0.90.4 209.7%   
Return on assets %13.63.6 378.8%  
Return on equity %19.25.6 341.7%  
Return on capital %24.94.9 504.1%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,259225,878 3.2%  
From Investments Rs m1,864-80,038 -2.3%  
From Financial Activity Rs m-9,273-270,956 3.4%  
Net Cashflow Rs m-150-125,116 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.78 Rs / USD

Compare ALKEM LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALKEM LABORATORIES With: SUN PHARMA  NOVARTIS  IPCA LABS  STRIDES SHASUN LTD  UNICHEM LAB  



Today's Market

Of Rupee's Fall, China's Investment Growth, and Top Stocks in Focus Today(Pre-Open)

On Tuesday, Indian share markets ended the day on a positive note with gains were largely seen in the healthcare sector, realty sector and energy sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 14, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - FRESENIUS KABI ONCO. COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS